These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1730830)

  • 1. Conjunctival hyperresponsiveness to ocular histamine challenge in patients with vernal conjunctivitis.
    Bonini S; Bonini S; Schiavone M; Centofanti M; Allansmith MR; Bucci MG
    J Allergy Clin Immunol; 1992 Jan; 89(1 Pt 1):103-7. PubMed ID: 1730830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emedastine ophthalmic solution 0.05% versus levocabastine ophthalmic suspension 0.05% in the treatment of allergic conjunctivitis using the conjunctival allergen challenge model.
    Netland PA; Leahy C; Krenzer KL
    Am J Ophthalmol; 2000 Dec; 130(6):717-23. PubMed ID: 11124289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impression cytology of the conjunctival epithelium in patients with vernal conjunctivitis.
    Aragona P; Romeo GF; Puzzolo D; Micali A; Ferreri G
    Eye (Lond); 1996; 10 ( Pt 1)():82-5. PubMed ID: 8763308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significance of perilimbal conjunctival pigmentation in vernal conjunctivitis.
    Khan FA; Khan Niazi SP; Awan S
    J Coll Physicians Surg Pak; 2012 Jan; 22(1):19-22. PubMed ID: 22237184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperosmolar conjunctival provocation for the evaluation of nonspecific hyperreactivity in healthy patients and patients with allergy.
    Sacchetti M; Lambiase A; Aronni S; Griggi T; Ribatti V; Bonini S; Bonini S
    J Allergy Clin Immunol; 2006 Oct; 118(4):872-7. PubMed ID: 17030240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital.
    Adefule-Ositelu AO; Onakoya AO; Olasimbo OO; Adefule AK
    Niger Postgrad Med J; 2006 Mar; 13(1):35-40. PubMed ID: 16633377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model.
    Abelson MB; Greiner JV
    Curr Med Res Opin; 2004 Dec; 20(12):1953-8. PubMed ID: 15701212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activity.
    Abelson MB; Spitalny L
    Am J Ophthalmol; 1998 Jun; 125(6):797-804. PubMed ID: 9645717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine H4 receptors in normal conjunctiva and in vernal keratoconjunctivitis.
    Leonardi A; Di Stefano A; Vicari C; Motterle L; Brun P
    Allergy; 2011 Oct; 66(10):1360-6. PubMed ID: 21545429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine effects on conjunctival fibroblasts from patients with vernal conjunctivitis.
    Leonardi A; Radice M; Fregona IA; Plebani M; Abatangelo G; Secchi AG
    Exp Eye Res; 1999 Jun; 68(6):739-46. PubMed ID: 10375437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of comfort using olopatadine hydrochloride 0.1% ophthalmic solution in the treatment of allergic conjunctivitis in contact lens wearers compared to placebo using the conjunctival allergen-challenge model.
    Brodsky M; Berger WE; Butrus S; Epstein AB; Irkec M
    Eye Contact Lens; 2003 Apr; 29(2):113-6. PubMed ID: 12695716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis.
    Williams JI; Kennedy KS; Gow JA; Torkildsen GL; Abelson MB; Gomes PJ; McNamara TR;
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):385-93. PubMed ID: 21649522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the efficacy of epinastine ophthalmic solution using a conjunctivitis allergen challenge model in patients with birch pollen allergic conjunctivitis.
    Tagawa Y; Namba K; Nakazono Y; Iwata D; Ishida S
    Allergol Int; 2017 Apr; 66(2):338-343. PubMed ID: 27720602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases.
    Leonardi A; Borghesan F; Faggian D; Depaoli M; Secchi AG; Plebani M
    Am J Ophthalmol; 2000 Feb; 129(2):151-8. PubMed ID: 10682966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histamine and tryptase levels in allergic conjunctivitis and vernal keratoconjunctivitis.
    Fukagawa K; Saito H; Azuma N; Tsubota K; Iikura Y; Oguchi Y
    Cornea; 1994 Jul; 13(4):345-8. PubMed ID: 7924335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The conjunctival provocation test model of ocular allergy: utility for assessment of an ocular corticosteroid, loteprednol etabonate.
    Abelson M; Howes J; George M
    J Ocul Pharmacol Ther; 1998 Dec; 14(6):533-42. PubMed ID: 9867336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
    Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR;
    Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge.
    Fujishima H; Ohashi Y; Takamura E
    Ann Allergy Asthma Immunol; 2014 Oct; 113(4):476-81. PubMed ID: 25163405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of allergic conjunctivitis by thermography.
    Hara Y; Shiraishi A; Yamaguchi M; Kawasaki S; Uno T; Ohashi Y
    Ophthalmic Res; 2014; 51(3):161-6. PubMed ID: 24603108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of ketotifen fumarate 0.025% ophthalmic solution compared with placebo in the conjunctival allergen challenge model.
    Abelson MB; Chapin MJ; Kapik BM; Shams NB
    Arch Ophthalmol; 2003 May; 121(5):626-30. PubMed ID: 12742839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.